MaxLinear Q4 Adj EPS $0.01, Inline, Sales $125.35M Beat $125.11M Estimate
Portfolio Pulse from totan@benzinga.com
MaxLinear (NASDAQ:MXL) reported Q4 adjusted EPS of $0.01, matching analyst estimates, but representing a 99.07% decrease from $1.07 per share a year ago. Sales were $125.35M, slightly above the $125.11M estimate, yet marked a 56.86% decrease from $290.59M in the same quarter last year.
January 31, 2024 | 9:23 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
MaxLinear's Q4 earnings met expectations but showed a significant decrease from the previous year. Sales exceeded estimates but also declined year-over-year.
While MaxLinear met EPS estimates, the drastic decrease in earnings compared to the previous year and the significant drop in sales could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100